The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -5.50% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -15.69%. Over the past 30 days, the price of EYPT has fallen by 3.83%. And in the last five days, it has surged by 13.37%.
EyePoint Pharmaceuticals Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $13.98 on 10/28/24, while the lowest price during the same period was $3.91 on 04/09/25.
52-week price history of EYPT Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. EyePoint Pharmaceuticals Inc’s current trading price is -49.66% away from its 52-week high, while its distance from the 52-week low is 80.05%. The stock’s price range for this period has been between $3.91 and $13.98. The Healthcare sector company’s shares saw a trading volume of about 2.53 million for the day, which was higher than the average daily volume of 0.78 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly rise of 19.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 484.44M and boasts a workforce of 165 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.55, with a change in price of -0.41. Similarly, EyePoint Pharmaceuticals Inc recorded 826,346 in trading volume during the last 100 days, posting a change of -5.50%.
EYPT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EYPT stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.07.
EYPT Stock Stochastic Average
As of today, the raw stochastic average of EyePoint Pharmaceuticals Inc over the last 50 days is at 88.42%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 80.93%. Further, the company’s Stochastic %K and %D values for the last 20 days were 43.10% and 27.18%, respectively.
